Benzinga · Aug 14, 2026
Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $21 to $15.
CL
NASDAQ · CLBT
Cellebrite DI Ltd.
Technology · Software - Infrastructure
$11.00
Up+$0.04 (+0.32%)
Updated Aug 19, 2026, 2:53 PM
SID Score
3.8/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 4.66B
- P/E ratio
- -30.36
- Dividend yield
- 0.00%
- 52-week range
- $9.58 – $17.05
- Volume
- 7.73M
- Avg. volume
- 1.37M
Price performance
CLBT price history
1M range · 21 trading sessions · Daily adjusted prices
CLBT closed at $11.00 after 21 trading sessions, down 25.42% for the selected period.
- Last close
- $11.00
- Period change
- -25.42%
- Period low
- $10.44
- Period high
- $16.03
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $10.44 | $11.04 | $10.32 | $11.00 | 7.73M |
| Aug 17, 2026 | $11.19 | $11.42 | $10.325 | $10.44 | 8.23M |
| Aug 14, 2026 | $10.83 | $11.20 | $10.78 | $11.14 | 7.85M |
| Aug 13, 2026 | $10.32 | $10.83 | $9.58 | $10.80 | 36.75M |
| Aug 12, 2026 | $15.79 | $16.10 | $15.06 | $15.25 | 2.88M |
| Aug 11, 2026 | $15.82 | $16.43 | $15.72 | $16.03 | 2.12M |
| Aug 10, 2026 | $15.68 | $16.39 | $15.68 | $15.90 | 861.27K |
| Aug 7, 2026 | $15.83 | $16.01 | $15.42 | $16.01 | 854.98K |
| Aug 6, 2026 | $15.20 | $15.645 | $15.01 | $15.46 | 644.52K |
| Aug 5, 2026 | $15.81 | $15.97 | $15.44 | $15.64 | 691.04K |
| Aug 4, 2026 | $14.87 | $15.80 | $14.81 | $15.78 | 944.38K |
| Aug 3, 2026 | $15.00 | $15.38 | $14.80 | $15.07 | 948.77K |
| Jul 31, 2026 | $14.45 | $14.825 | $14.35 | $14.75 | 650.96K |
| Jul 30, 2026 | $14.85 | $14.9171 | $14.16 | $14.57 | 952.55K |
| Jul 29, 2026 | $14.84 | $15.35 | $14.61 | $15.07 | 1.5M |
| Jul 28, 2026 | $14.67 | $15.08 | $14.45 | $14.85 | 957.7K |
| Jul 27, 2026 | $14.55 | $14.89 | $14.45 | $14.64 | 902.96K |
| Jul 24, 2026 | $14.32 | $14.41 | $14.09 | $14.215 | 957.51K |
| Jul 23, 2026 | $14.27 | $14.38 | $13.87 | $14.06 | 1.09M |
| Jul 22, 2026 | $14.74 | $14.795 | $14.055 | $14.18 | 1.81M |
| Jul 21, 2026 | $15.14 | $15.34 | $14.67 | $14.75 | 1.7M |
Latest CLBT news
The latest Smart Investors Daily articles mentioning CLBT.
Stock researchCompany · Overview
CLBT research
Overview
Company profile and research snapshot.
Company profile
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $20.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2026 | Lake Street | Buy | — |
| Aug 14, 2026 | JP Morgan | Overweight | — |
| Aug 14, 2026 | DA Davidson | Buy | — |
| Aug 14, 2026 | Needham | Buy | — |
| Aug 6, 2026 | DA Davidson | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 14, 2026
JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16
JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $20 to $16.
Benzinga · Aug 14, 2026
DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.
Benzinga · Aug 14, 2026
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $12.5
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $15 to $12.5.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
